Britannia Life Sciences Inc. (CSE:BLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
0.00 (0.00%)
At close: Feb 9, 2026
Market Cap16.23M +42.9%
Revenue (ttm)260.58K -28.5%
Net Income8.22M
EPS0.05
Shares Out162.25M
PE Ratio1.97
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume76,000
Average Volume177,777
Open0.1000
Previous Close0.1000
Day's Range0.1000 - 0.1000
52-Week Range0.0500 - 0.1400
Beta-0.12
RSI63.05
Earnings DateFeb 27, 2026

About Britannia Life Sciences

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Peter Shippen
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol BLAB
Full Company Profile

Financial Performance

Financial Statements